Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

BAX – Baxter International Inc.

Float Short %

3.75

Margin Of Safety %

48

Put/Call OI Ratio

1.03

EPS Next Q Diff

0.11

EPS Last/This Y

3.72

EPS This/Next Y

0.16

Price

24.52

Target Price

26.92

Analyst Recom

2.75

Performance Q

-18.93

Relative Volume

1.05

Beta

0.59

Ticker: BAX




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25BAX29.230.620.7659125
2025-07-28BAX28.510.530.0755992
2025-07-29BAX28.870.430.0764809
2025-07-30BAX28.080.391.2871818
2025-07-31BAX21.760.421.1675527
2025-08-01BAX21.950.860.29285012
2025-08-04BAX22.440.830.97286033
2025-08-05BAX22.850.830.53287111
2025-08-06BAX22.50.840.22287681
2025-08-07BAX23.530.830.18289066
2025-08-08BAX23.680.820.39290965
2025-08-11BAX23.480.820.27287945
2025-08-12BAX23.940.820.12288714
2025-08-13BAX24.110.820.22289430
2025-08-14BAX24.450.820.58289781
2025-08-15BAX24.170.820.69290453
2025-08-18BAX23.61.021.52256806
2025-08-19BAX24.351.030.23258390
2025-08-20BAX24.261.020.45259044
2025-08-21BAX23.881.021.31259309
2025-08-22BAX24.521.030.68259246
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25BAX29.22-10.51456.42.51
2025-07-28BAX28.52-10.41418.02.52
2025-07-29BAX28.84-10.41452.02.52
2025-07-30BAX28.05-10.41414.82.52
2025-07-31BAX21.76-10.41226.72.52
2025-08-01BAX21.96-10.41449.22.52
2025-08-04BAX22.44-25.61460.32.46
2025-08-05BAX22.84-25.61456.82.46
2025-08-06BAX22.50-25.61032.32.45
2025-08-07BAX23.54-25.61087.62.45
2025-08-08BAX23.69-25.61062.12.45
2025-08-11BAX23.48-25.61052.12.45
2025-08-12BAX23.95-25.01071.62.45
2025-08-13BAX24.11-25.51061.52.45
2025-08-14BAX24.44-25.51067.02.45
2025-08-15BAX24.17-25.51050.32.45
2025-08-18BAX23.60-25.51042.02.45
2025-08-19BAX24.33-25.51077.92.45
2025-08-20BAX24.27-25.51056.32.45
2025-08-21BAX23.86-25.51046.72.45
2025-08-22BAX24.52-25.51076.52.45
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25BAX0.002.453.60
2025-07-28BAX0.002.023.60
2025-07-29BAX0.002.023.60
2025-07-30BAX0.002.023.60
2025-07-31BAX0.002.023.60
2025-08-01BAX0.002.023.60
2025-08-04BAX0.003.373.60
2025-08-05BAX0.003.373.60
2025-08-06BAX0.003.373.60
2025-08-07BAX0.003.373.60
2025-08-08BAX0.003.373.60
2025-08-11BAX0.003.093.60
2025-08-12BAX0.003.093.75
2025-08-13BAX0.003.093.75
2025-08-14BAX0.003.093.75
2025-08-15BAX0.003.093.75
2025-08-18BAX0.003.013.75
2025-08-19BAX0.003.013.75
2025-08-20BAX0.003.013.75
2025-08-21BAX0.003.013.75
2025-08-22BAX0.003.013.75
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.59

Avg. EPS Est. Current Quarter

0.6

Avg. EPS Est. Next Quarter

0.7

Insider Transactions

Institutional Transactions

3.01

Beta

0.59

Average Sales Estimate Current Quarter

2875

Average Sales Estimate Next Quarter

3004

Fair Value

36.18

Quality Score

46

Growth Score

46

Sentiment Score

20

Actual DrawDown %

72.7

Max Drawdown 5-Year %

-73.5

Target Price

26.92

P/E

Forward P/E

9.45

PEG

P/S

1.16

P/B

1.72

P/Free Cash Flow

36.12

EPS

-0.27

Average EPS Est. Cur. Y​

2.45

EPS Next Y. (Est.)

2.6

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1.23

Relative Volume

1.05

Return on Equity vs Sector %

-26.8

Return on Equity vs Industry %

-11

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.07

EBIT Estimation

1076.5
Baxter International Inc.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 38000
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It has an agreement with Celerity Pharmaceuticals, LLC to develop acute care generic injectable premix and oncolytic products. The company operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
stock quote shares BAX – Baxter International Inc. Stock Price stock today
news today BAX – Baxter International Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BAX – Baxter International Inc. yahoo finance google finance
stock history BAX – Baxter International Inc. invest stock market
stock prices BAX premarket after hours
ticker BAX fair value insiders trading